United States

Health News


J&J ordered to pay $417 million in trial over talc cancer risks 3:39pm EDT

A California jury on Monday ordered Johnson & Johnson to pay $417 million to a woman who claimed she developed ovarian cancer after using the company's talc-based products like Johnson's Baby Powder for feminine hygiene.

More Headlines


Britain's Creo receives speedy FDA approval for its endoscopic device

LONDON Britain's Creo Medical Group said its device to remove cancerous lesions in the bowel during an endoscopy had received U.S. approval much quicker than it planned, shaking up a timetable that had been focused on a European launch.

7:56am EDT

ASL Strategic Fund asks Community Health to replace CEO

ASL Strategic Value Fund has sought the replacement of hospital operator Community Health Systems Inc's chief executive, Wayne Smith.

12:24pm EDT

New Novartis drug takes aim at tough-to-treat malaria

LONDON Novartis is taking aim at drug-resistant malaria – a growing global problem – by launching clinical trials of the first new antimalarial medicine for many years in nine countries across Africa and Asia.

3:29am EDT

Shire's CFO resigns to join plant technology start-up

LONDON Pharmaceutical company Shire said its chief financial officer Jeff Poulton will stand down at the end of the year to join Indigo Ag, a Boston-based start-up that seeks to improve agricultural productivity.

10:14am EDT

Health Watch Graphics